MIME-Version: 1.0 Content-Type: multipart/related; boundary="----=_NextPart_01D7EA15.3E0692F0" Este documento é uma Página da Web de Arquivo Único, também conhecido como Arquivo Web. Se você estiver lendo essa mensagem, o seu navegador ou editor não oferece suporte ao Arquivo Web. Baixe um navegador que ofereça suporte ao Arquivo Web. ------=_NextPart_01D7EA15.3E0692F0 Content-Location: file:///C:/E87559EC/RESUMOSSGWACm2021GANHADORESHTML.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="windows-1252"

WINNERS OF THE "DR. WALTER SOARES PINTO" E-POSTER AWARD AT= THE SGAWCM 2021 – SOBRATAFE GLOBAL ADVANCED WOUND CARE MEETING 2021<= /span>

GANHADORES DO PRÊMIO “DR. WALTER SOARES PINTO” DE E-POSTER NO SGAWCM 2021 – SOBRATAFE GLOBAL ADVANCED WOUND CARE MEETING 2021<= /span>

 <= /o:p>

MODALITY: ACADEMICS

 

397580 - MEROPENEM PHARMACOKINETICS CHAN= GES DURING THE SEPTIC SHOCK WITH IMPACT ON COVERAGE BASED ON PK/PD APPROACH IN CRITICALLY BURN PATIENTS

Claudia G Messiano1 * Els= on M Silva Junior2 * João Manoel da Silva Junior2 * Edvald= o V Campos2 * Amanda M R R Oliveira= 2 * Aline S Gomides2 *  Ga= briela A Ferreira2 * Thiago C Oliveira2 * David de Souza Gom= ez2 * Silvia R C J Santos1

1        Clinical Pharmacokinetics Center, School of Pharmaceutical Sciences, University of Sao Paulo, Brazil.

2        Division of Plastic Surgery and Burns, HCFMUSP, Medical School; University of Sao Paulo/SP, Brazil

 

Introduction: Physiological change that occurs during the time course septic shock in burn patients can alter pharmacokinetics (PK) of hydrophilic beta-lactam agents, which could impact the desired outcome in I= CU patients undergoing meropenem therapy [1]. Rational of study was to investi= gate PK changes during the time course of therapy of septic shock in burn patien= ts receiving meropenem 1g q8h by 3hrs-extended infusion that could impact the desired outcome. Methods: Ethical approval was obtained, and the con= sent forms were signed before the study starts. Ten burn patients undergoing intensive care therapy with preserved renal function were included. Cultures were collected prior to starting the antimicrobial therapy. Blood was sampl= ing (1.5 mL/each) at the steady state, at the 3rd and at the 5th of infusion st= arts 1g q8h, for drug serum measurement by liquid chromatography in three consecutive periods as follows: Set 1 at the 3rd day, S= et 2 at 10th day, Set 3 at 17th day [2]. PK data was based on noncompartimental data analysis in burn patients by comparison with results previously descri= bed in healthy volunteers [3]. Furthermore, pharmacokinetics data obtained from each patient were compared between Sets. Predictive index of drug effective= ness was based on %fDT>MIC for therapeutic target considered of 100%= fDT>MIC.= Results: Characteristics of patients (7M/3F) included were as follows: 37 yrs, 75 kg, 34% total burn surface area, SAPs score 5= 3, medians. Inhalation injury, mechanical ventilation and vasopressors requirements occurred in 8/10 patients undergoing therapy of septic shock w= ith meropenem 1g q8h, extended 3hr infusion. Patients received 42 mg/kg (39-43 mg/kg) daily dose equivalent to dose regimen of 14.5 mg/kg (13-14 mg/kg) q8= hr, medians (quartiles). It was shown a prolongation of elimination half-life a= nd increases by trice on the volume of distribution at the earlier stage of se= ptic shock (Set 1) with positive impact on drug effectiveness. It is important to highlight that PK changes were reduced in the subsequent period (Set 2); in= Set 3 data from patients were comparable with values reported in healthy volunteers. Then, target was attained for all septic burn patients in Set 1= and in Set 2 against gram-negative strains up to MIC 4mg/L and reduced to 8/10 patients in Set 3. Conclusion: It is important to highlight that meropenem 1g q8h must be prescribed at the onset of septic shock with the strategy of extended infusion, since the antimicrobial coverage will be guaranteed up to 9-10 days of therapy. Consequently, desired outcome was impacted by meropenem PK-changes during the time course of septic shock in = burn patients (Sets 1-2) by eradication of pathogens isolated, and cure of infection. Then, drug prescription soon and PK/PD approach is an important strategy to avoid microbial resistance.    =
Keywords: Pharmacokinetics Changes; Septic Shock; Outcome; Serum Mon= itoring of the Meropenem; PK/PD Approach.

_____________

REFERENCES

1Carlier M. et al. Assays for therapeutic drug monitoring of beta-lactâmics antibiotics:A structure review. Int. J. Antimicrob. Agent. 2015;46:367-75.

2 Jaruratanasirikul S,= Sriwinyajan S. Stability of meropenem in normal saline solution after storage at room temperature. Southeast Asian J Trop Med Publ= ic Health. 2003;34(3):627–9.

3 Santos SRCJ, Sanches-Giraud C, De Souza FF. Gómez DS. Campos RV, Azevedo R, Ferreira M, Nascimento J. PhatmacoKinetic-pharmacpdymamic correlation for meropenem applied to a burn child using a bioanalytical liquid chromatographic method. Rev Portuguesa de Farmacoterpia. 2011;3(4): 224-32.

 

MODALITY: CASE RE= PORT OF GREAT SCIENTIFIC RELEVANCE

420065 - = USE OF LOW-LEVEL LIGHT AND PHOTODYNAMICS THERAPIES IN THE TREATMENT OF PIODERMA GANGRENOUS INJURY

Maria Elena Echevarría Guanilo1 * Pa= ulo Roberto Boeira Fúculo Junior1 * Alexsandra Martins da Silva1 * Guilherme Lu= iz Pacher Schmitz1 * Marlei Sangalli1 * Luis Gustavo Ferreira da Silva2 * Leonardo Franco Pereira2= .

1 Federal University of Santa Catarina – UFSC <= /span><= /o:p>

2 University Hospital Professor Polydoro Ernani d= e São Thiago

 

 

Objective: To report the treatment of a patient with pyoderma gangrenous lesio= n by using low-level light and photodynamic therapies. Case report: Male,= 36 years old, attended at a plastic surgery outpatient service, showing a 14x8= cm lesion on the inner side of the right leg and a second one of 34.5x17.5cm on the anterior surface of the left leg. He reports that the lesion started fr= om a superficial hemorrhagic pustule, which appeared after skin trauma and evolv= ed into a red-purple ulcerated lesion with the predominance of necrotic tissue, irregular margins, erythematous-violet and high borders, with an intense inflammatory process and complaint of severe pain. Past history includes rheumatoid arthritis and Klinefelter syndrome. The patient was treated by a rheumatology, endocrinology, plastic surgery and nursing team, from 3/20/20= 20 to 3/5/2021 that provided him with the pharmacological needs due to autoimm= une disease (infliximab), with analgesic (tramadol hydrochloride and paracetamol/codeine) due to intense pain (Numerical scale pain assessment 0= to 10 =3D 9 / constant and throbbing), with broad-spectrum antibiotic therapy = due to different conditions of infection of the lesions, who in addition required hospitalization and dressings (once a week) by the nursing team and received guidelines for home care. During this period, he had difficulties to adapt himself to the therapy with topical agents and autolytic enzymatic debridem= ent or with hydro-fiber coatings with silver or foam with anti-inflammatory. In= one year, there was a reduction in the extent of the lesions to 25x9cm and 9x8c= m, of lesions with irregular surface, abundant exudate, intense edema (3+/4+) = and the need for three hospitalizations and three debridem= ents in the operating room. 7 On 3/12/2021, the adjuvant treatment with 100mw low-intensity laser has started through weekly application of combined ther= apy of 01 Joule Infrared (808nm) and 01 Joule Red (660 nm), on every 1cm from t= he edges and in the granulation tissue, followed by application of 1% methylene blue and irradiated with a red LED board for 10 minutes, and the choice of = foam cover with silver of adhering silver. After two cycles of 10 laser applicat= ions once a week, the following results has been obtained: lesion dimensions decreased to 17.6x4.3cm (left leg) and 3.3x2.3cm (right leg), flat and regu= lar surface, without need for further hospitalization or surgical approach, significant reduction of exudate (medium to small amount), pinkish and hydr= ated edges, perilesional/scar tissue with positive qualitative assessment regard= ing elasticity, hydration, and oiliness. The patient presents decreased edema in the legs (+/4+) and pain reduction (from nine to pain 4, when dressings are applied and zero during the day). Conclusion: It stands out the importance of the multidisciplinary approach and the use of adjuvant treatm= ent in the healing of complex injuries.

Keywords: Low-Level Light Therapy; Photodynamic Therapy; Wounds and Injuries; Pyoderma Gangrenosum.

REFERENCE

1.      E= ran Shavit<= span style=3D'box-sizing: inherit;display:inline-block;font-variant-ligatures: n= ormal; font-variant-caps: normal;orphans: 2;text-align:start;widows: 2;-webkit-tex= t-stroke-width: 0px; text-decoration-thickness: initial;text-decoration-style: initial;text-deco= ration-color: initial; word-spacing:0px'>Afsaneh AlaviR Gary Sibbald,  Pyoderma Gangrenosum: a Critical Appraisal. Adv Skin Wound Care. 2017 Dec;30(12):534-542. Doi: 1097/01.ASW.0000526605.34372.9e.<= /span>

 

  1. Maverakis E, Marzano AV, Le ST, Callen JP, Brüggen= MC, Guenova E, Dissem= ond J, Shinkai K, Langan<= /span> SM. Pyoderma gangrenosum. Nat Rev Dis Primers. 2020 Oct 8;6(1):81.
  2. Dungel P, et al. Low-level light therapy by LED of different wavelen= gth induces angiogenesis and improves ischemic wound healing. Lasers Surg = Med. 2014. PMID: 25363448.
  3. Avci P, Gupta A, Sadasivam M, Vecchio = D, Pam Z, Pam N, Hamblin MR. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg. 2013 Mar;32(1):41-52= .

 

MODALITY: EXPERIMENTAL WORK<= /p>

403313 - OZONE THERAPY TRANSCUTANEOUS VER= SUS FOTOBIOMODULATION IN TREATING BURN

Juliana Balbinot Reis Girondi1 * Fel= ipe Duarte1 * Julia Grisard de Bem1 * Ca= rla do Rosário1 * Milena Ronise Calegari1 * Lucia Nazareth Amante1 * Cilene Fernandes Soares1 <= span class=3DSpellE>Luciara Fabiane Sebold1<= /b>

1&nb= sp;       Federal University of Santa Catarina

Objective: to compare the use of photobiomodulation with ozone therapy in the treatment of burns. Method: case study of a 40-year-old man without comorbidities presenting second-degree thermal burns caused by cooking oil in the left lower limb. Patient with severe pain, tre= ated in May 2021 (10 days after the injury) at the plastic surgery team outpatie= nt clinic (physician and residents, nurse and nursing students) of a teaching hospital in southern Brazil. Lesion measuring 748 cm² (44X17) in the antero= lateral tibial regionextensive to the dorsum of the foo= t, toes and calf with 80% granulation and 20% sloughing; delimited, regular and adhered edges; perilesional area with maceration. Hygiene and instrumental debridement¹ was performed, weekly treatment was started with Low Intensity Laser (LLL) in 25 cm from the upper region of the lesion, frequency 660nm 1J by punctual technique (40 points), radiance 10J;= and in the remainder of the wound, an ozone bag was used, dos and 90 mcg for 30= minutes. As primary coverage, hydrofiber with silver was= used and, in the final stage of healing, gauze with petrolatum. At home, the dressings were performed by the wife, as instructed by the nursing team. A total of five consultations were carried out, from the third onwards, only ozone therapy was maintained, and after the fourth, the dose was changed fr= om 90 mcg to 20 mcg. At outpatient discharge, the use of a 20-mmHg compression stocking was prescribed. The research was approved by the ethics committee = for research with human beings. Results: In the area where it was applie= d only ozone transcutaneous by lowering bag was 30 cm 2 of total area after the fi= rst application, better vascularization, epithelialization and quality of the regenerated ti= ssue. In total, five sessions of ozone therapy were performed with total tissue repair and outpatient discharge within four weeks. Conclusion: In the case described it is inferred that the Ozone therapy transcutaneous a bag showed better results the treatment of patients with burn especially having antimicrobial activity, given the exponential risk for these patients to infections and by decreasing oxidative stress due to the action on cytochro= me C oxidase through its byproducts: reactive oxygen species (ROS) and lipid oxygenation products (LOPs). New clinical studies are suggested with expans= ion of the investigated sample and in new care contexts.

Keywords: Stomatherapy; Burns; Ozone; Low Intensity Light Thera= py.

 

REFERENCE

  1. Murphy C, Atkin L, Swanson T, Tachi M, Tan YK, Vega de Ceniga M, Weir D, Wolcott = R. International consensus document. Defying hard-to-heal wounds with an early antibiolm intervention strategy: wou= nd hygiene. J Wound Care 2020; 29(Suppl 3b):S1–28= .
  2. Associação Espanhola de Profissionais Médicos de Ozonoterapia (M= adrid). Declaração de Madrid Sobre Ozonoterapia. 2010. Disponível em: http://www.spozonoterapia.com/pdf/portuguese_declaration.pdf.
  3. Lima NEP, Gomes GDM, Feitosa ADNA, Bezerra ALD, Sousa MNA de. Laser therapy low intensity in wound = care and practice nurses. Rev Enferm da UFPI [Internet]. 2018 May 13;7(1):5= 0. Available from: http://www.ojs.ufpi.br/index.php/reufpi/article/view/6= 223

&nbs= p;

403315 - = OZONE THERAPY IN THE THERAPEUTIC APPROACH TO THE MANAGEMENT OF LEUKOCYTOCLASTIC VASCULITIS

Juliana Balbinot Reis Girondi1 * Fel= ipe Duarte1 * Julia Grisard de Bem1= * Carla do Rosário1 * Milena Ronise Calegari1 * Lucia Nazareth Amante1 * Cilene Fernandes Soares1 Aldanea Norma de Souza Silve= strin1

1 Federal University of Santa Catarina.

Objective: To report a case of leukocytoclastic vasculitis treated with transcutaneous ozone therapy. Method: case s= tudy of a 74-year-old woman with type II Diabetes Mellitus, Systemic Arterial Hypertension, Depression and a history of allergy to diclofenac and ceftriaxone. Possible control of capillary blood glucose at home ranging between 150-200 mg/dl. Referred to the plastic surgery outpatient service (physician and residents, nurses and nursing students) of a teaching hospit= al in southern Brazil for the treatment of leukocytoclast= ic vasculitis in the lower limbs with a to clarify. In the first visit, in May 2021, he presented intense pain and lesions that permeated the entire lengt= h of the feet and ankles of both limbs, with the presence of ruptured blisters, large amounts of slough and seropurulent exudate, purpura and necrotic regi= ons. No conditions to measure the lesions by the extension and clinical status of the patient. Wound hygiene was performed with polyhexa= methylene biguanide solution and instrumental debridement. Weekly treatment started w= ith transcutaneous ozone per bag, dose 90 mcg for 30 minutes. As primary covera= ge, hydrofiber with silver was used in the first visit, a= nd foam with adhesive-edged silver and gauze with petrolatum in the others. At outpatient discharge, maintenance of hydration and general health care were prescribed. The research was approved by the ethics committee for research = with human beings. Results: In the second visit in June 2021, patient with improvement in general condition and pain control. Significant reduction in injured areas: left limb with lesion in the malleolar region 4x3 (12 cm2) with 95% granulation and 5% slough, right limb with lesion on the dorsum of= the foot 8.5x4 (34 cm2) 100% granulated. A total of four consultatio= ns were carried out, with the application of two sessions of ozone therapy in = 21 days the lesions were completely healed. Conclusion: Ozone therapy w= as used in the adjuvant treatment to obtain the effects of antimicrobial activ= ity, increased angiogenesis, modulation of inflammation, decrease stress of oxidative cell, promotion of analgesia and regulation of cellular metabolis= m. These associated factors favored healing quickly and effectively, in additi= on to providing a better quality of life for the patient. New clinical studies= are suggested with the expansion of the investigated sample and in new care contexts.

Keywords: Stomatherapy; Ozone; Cutaneous Leukocytoclastic Vasculitis.

 

REFERENCE

  1. Gonçalves MS. Vasculites: desafio diagnóstico e terapêutico. Arq Catarinenses = Med [Internet]. 2019;48(4):174–90. Available from: http://www.acm.org.br/acm/seer/index.php/arquivos/article/view/531/388=
  2. Murphy C, Atkin L, Swanson T, Tachi M, Tan YK, Vega de Ceniga M, Weir D, Wolcott R. International consensus document. Defying hard-to-heal wounds with an early antibiolm intervention strategy: wou= nd hygiene. J Wound Care 2020; 29(Suppl 3b):S1= –28.
  3. Girondi J, et al. Ozonioterapia no tratamento de feridas em adultos: revisão integrativa. Brazilian J Dev [Internet]. 2021; 7 (7): 68912–25. DOI: 10.34117/bjdv7n7-191.<= /li>

 

MODALITY: HEALTH PROFESSIONALS BASIC CAREER WORK

397070 - = ASSOCIATION OF HYPERBARIC OXYGEN THERAPY AND LASER THERAPY IN THE HEALING OF ACHILLES TENDON RUPTURE

Rauza Bretas Beck1

1 Institute of Hyperbar= ic Medicine of Brazil

Introduction: Achilles tendon injury can result in poor quality of life for the patient due to its functional mobility. In addition= , it is a great challenge for the health team to work on the regeneration of this injury and functional rehabilitation. Among the new technologies available = for the treatment of wounds is hyperbaric oxygen therapy (HBOT), which consists= of the application of 100% oxygen in hyperbaric chambers, aiming at systemic h= yperoxia in the body, accelerating the healing process. Laser therapy also emerges a= s a new technology in the treatment of wounds which, together with hyperbaric effects, enhances local action by acting on cellular and biochemical events= . Objective: To describe the benefits of the association of hyperbaric oxygen therapy and laser therapy in the healing of Achilles tendon rupture. Method: Thi= s is a qualitative research of the type experience report. The case was experienced by a nurse in a private HBOT clinic/RS. The ethical precepts were met, the patient signed the informed consent authorizing her images and case report. Result: A 56-year-old female patient, with a history of hypertension and controlled Diabetes Mellitus, underwent 3 surge= ries after the Achilles tendon rupture and 3 more surgeries after starting treat= ment with HBOT for complete removal of the nylon thread, which was causing a rejection by the body itself. The last surgery was performed on 20/06/21, in which the lesion measured 8.0x 2.0 cm with granulation tissue in the center= and a medium amount of serous exudate. After performing 53 sessions of HBOT, the lesion was cleaned with heated SF0.9%, and the 1st session of laser therapy= was performed using 0.5 joules of red laser in the path of the points and 2 jou= les of infrared at cardinal points in the granulation region. The wound was clo= sed with rayon gauze, sterile gauze and bandage. The same procedure was repeate= d on 27/06/21, 02/07/21, 09/07/21/, 16/07/21 and 30/07/21. On 08/07/21 the stitc= hes were removed. The treatment was completed with 6 sessions of laser therapy = and 72 sessions of HBOT with good progress on the lesion, epithelialized tissue, measuring 0.5 cm without exudate. Conclusion: Favorable developments were found when combining the two measures, enhancing what the therapeutic literature has been showing in relation to the benefits of the combine measures. Exposure to high concentrations of O² increase oxygen saturation, forming neoangiogenesis and fibroblast prolifer= ation. This added to the stimulation of local laser therapy increase the productio= n of adenosine triphosphate (ATP), accelerating the healing process.<= /span>

Keywords: Hyperb= aric Oxygenation; Lasers; Healing.

 

REFERENCE

  1. Alves P. et al. Oxigenoterapia hiperbárica no processo de cicatrização de feridas: uma revisão de literatura. Rev Enfermagem atual in derme. 202= 0;93(31). Disponível em:  http://revista= enfermagematual.com.br/index.php/revista/article/view/610
  2. Barros DMK. tratamento da rotura crónica do Tendão de Aquiles. Mestrado integ= rado de medicina. U. Porto. Porto, 42 pag. 2019. https://repositorio-aberto= .up.pt/bitstream/10216/121269/2/343662.pdf.
  3. Lucena AF, et al. Laser em feridas: translação do conhecimento para uma prati= ca efetiva e inovadora na enfermagem. Rev. Gaúcha Enferm. 2021; 42:e20200= 396. Disponível em: http://revista.cofen.gov.br/index.php/enfermagem/articl= e/view/2375/766

 

MODALITY: HEALTH PROFESSIONALS CASE SERIES

382924 - = ASSOCIATION BETWEEN ANTIMICROBIAL PHOTODYNAMIC THERAPY AND PHOTOBIOMODULATION IN THE HE= ALING PROCESS OF SKIN WOUNDS IN DOG (CANIS LUPUS FAMILIARIS)

Fernando Alzamora F= ilho1 * Miriam Pinto Cavalcante2 * Larissa Oliveira Nepomuceno3 * Bruna Guedes de Carvalho4 * Manoel Luiz Ferreira5

1-      =            Departamento de Ciências Agrárias e Ambientais, Curso de Medicina Veterinária da Universidade Estadual de Santa Cruz (UESC), Ilhéus, BA, Brasil. E-mail: fafilho@uesc.br.

2-Médica Veterinária, BA, Brasil.

3-Discente do Curso de Medicina Veterinária da UESC, bolsista do Projeto Iniciação à Docência. Ilhéus – Bahia. =

4-Discente do Curso de Medicina Veterinária da Universidade do Grande Rio - Duque de Caxias, RJ, Brasil.

5-Centro de Cirurgia Experimental, Departamento= de Cirurgia. Faculdade de Medicina. Universidade Federal do Rio de Janeiro (UF= RJ), Rio de Janeiro, RJ, Brasil

 

Introduction: Wounds are common in Veterinary Medicine and they can be of different forms and origins. The healing process is complex and can be influenced by local and systemic factors, interfering with the different stages of healin= g. Treatment depends on the type of wound to restore the injured tissue. Laser therapy can be used alone or associated with other therapies and the effect= s on tissue damage are analgesia, inflammation modulation, angiogenesis and tiss= ue regeneration. Antimicrobial photodynamic therapy (aPDT= ) consists of the use of light, photosensitizer and oxygen, which generate reactive oxygen species and singlet oxygen, causing the microorganism to di= e. The objective was to publicize the use of laser therapy in a dog's skin wou= nd. Material and Methods: Female Border Collie, 3 years old, weighing 18 kg, suffered trauma with skin laceration on the left thoracic limb. The edges were sutur= ed, but there was dehiscence of the stitches within 24 hours. Second-intensity healing was recommended. Zinc oxide ointment (Alantol<= /span>= Ò) was administered daily, and antibiotic and anti-inflammatory for 5 days, cefadroxil (Cefa = Sid= Ò) and Meloxicam (Meloxivet= Ò), respectively, were administered. On physical examination, a wound with a swollen and reddish border, an ulcerated area w= ith devitalized tissue, serous exudate and 8.8 cm2 of injured area. It was deci= ded to associate photobiomodulation. The laser irradiation dosimetric parameters were calculat= ed according to the injured area and the sessions were three times a week. = Results: Due to the high degree of contamination of the wound, = aPDT was performed in the first session, red laser (λ =3D 660 nm), energy of 9J/point, pre-irradiation time of five minut= es and 0.01% methylene blue. After 48 hours of the 1st session, the lesion showed a reduction in edema and erythema, granulation tissue in the wound bed, absen= ce of exudate and a reduction of 3.8 cm2 in the injured area. The second session was with red laser (RL) and infrared (λ =3D 808nm) (IRL), with the energy used being 0.5 J/point and 1 J/point, respectively. The 3rd session was introduced aPDT, because the patient had contaminated and injure= d the granulation tissue and at the edge of the lesion, they were irradiated with IRL, five points of 1J of energy. The next four sessions were with RL in the open area, energy of 0.5J/point and IRL in the edge, energy of 1J/point, wi= th an interval between sessions of 48 hours. He observed a reduction in the op= en area, with the wound edge shifting to the center. On the 14th day, the heal= ing process was almost entirely completed, with a crust area of 0.4 cm2. Conclusion: Low-intensity laser therapy was effective in resolving t= he skin wound, modulating inflammation and accelerating tissue repair, in addi= tion to corroborating the conventional therapy used initially, enhancing its eff= ect.

Keywords: Healin= g; Photochemotherapy; Laser Therapy; Skin; Trauma.

 

REFERENCE

1&nb= sp;       Bagnato VS, Kurachi C, Blanco= KC, Inada NM. 2017.  Antimicrobial Phot= odynamic Therapy. In: Hamblin MR, Sousa MVP, Agrawal T.  (Eds).  Handbook of Low-Leve= l Laser Therapy.  Singapore:  Pan Stanford ublis= hing, pp.273-283.

2        Andrade FSSD, Clark RMO, Ferreira ML. 2014.  Effects of low-level laser therapy on wound healing.  Revista do Col= égio Brasileiro de Cirurgiões.  41(2): 1= 29-33.

3&nb= sp;       Kaviani=   A, Djavid G= E,  Ataie-Fashtami L, Fateh M, Geodis M, Salami M, Zand N, Kashef N,  Larijani B. 2011. A Randomized Clinical Trial on Effect of Low-Level Laser Therapy on Diabeti= c Foot Wound Healing: A Preliminary Report.  Photomedicine and laser Surgery. 29(2): 109-114. <= /p>

4&nb= sp;       Langella LG, Casalechi HL, Tomazoni SS, Johnson DS, Albertini R, Pallotta RC, Ma= rcos RL, Carvalho PTC, Leal-Junior ECP. 2018.  Photobiomodulation therapy (PBMT) on acute pain and inflammation in patients who underwent total hip arthroplasty-a randomized, triple-blind, placebo-controlled clinical trial.  Lasers Medicine Science. 33(9): 1933-19= 40.

            =                                                     

388491- MANAGEMENT OF SURGICAL WOUND DEHISCE= NCE IN A SPECIALIZED WOUND CARE CENTER: A CASE SERIES

Evelin Santos Figueiredo Lima¹ * Arthur César Pacheco Lopes2,3 * Tammila de Lima A= lmeida4 * Ana Flávia Novaes² * Luciana Moreira Lopes4 * Laís Oliveira Li= ma Barbosa2 * Joubert Felipe Luz Costa Brito2 * = Mariana Masimessi Fernandes2 * Raquel Araujo= da Silva Carneiro2 * Thiago de Carvalho Milet¹ * Bianca Tanajura Oliveira Bastos³

1-&n= bsp;    Health Department of the State of Bahia.

2-&n= bsp;    Federal University of Bahia.

3-&n= bsp;    Cicatrimed Comprehensive Wound Treatment=

4-&n= bsp;    Santo Agostinho Health Faculty.

 

Introduction: Surgical wound healing is the result of an orderly sequence of physiological events. A mechanical failure or failure in wound healing at t= he surgical site may evolve with the emergence of complications such as suture dehiscence. Specialized wound care has revolutionized the healthcare landsc= ape. This revolution also extends to the treatment of surgical wound dehiscence, which is a prevalent health problem. Objective: The aim of this study was to describe a series of cases of patients with surgical wound dehiscence admitted to Cicatrimed, a center specialized in wounds in the city of Vitória da Conquista, Bahia. Methods: The work= was structured based on the CARE case report guideline. Demographic information, symptoms, and patient history were used to describe the cases. The therapeu= tic tools used were described using schedules. The evolution of the wounds was described using images and clinical characteristics. Results: We described 7 cases of postoperative suture dehiscence in patients with the following diagnoses: post-abdominoplasty dehiscence, mammoplasty with prosthesis insertion, saphenectomy, hand trauma= and secondary amputation of diabetes mellitus. In all, there are remarkably sat= isfactory results with multidisciplinary treatment, hyperbaric oxygen therapy and oth= er wound care technologies. Conclusions: Its concluded that the specialized and comprehensive treatment of wounds has a potentially favorable role in the care of patients with surgical wound dehiscence, given the positive results from the use of different therapeutic instruments and, unfortunately, still not widespread in the care environmen= t as a whole.

Keywords: Surgical wound healing; suture dehiscence; multidisciplinary treatme= nt

 

REFERENCE

1&nb= sp;       Radowsky JS. et al. Preclosure spectroscopic differences between healed and dehisced traumatic wounds. PloS one, v. 13, n. 9, p. e0204453, 27 set. 2018.

2&nb= sp;       ramczykowski T, Schildhauer, T. Amputation und Prothesenversorgung – die untere ExtremitätZeitschrift für Orthopädie und Unfallchirurgie, 2017. Disponível em: http://dx.doi.o= rg/10.1055/s-0042-122394.

3&nb= sp;       Sandy-Hodgetts K, Carville K, Leslie GD. Surgical wound dehiscence: a conceptual framework= for patient assessment. Journal of wound care. Mar. 2018; 2= 7( 3): 119–26.

4&nb= sp;       Sanford Guide. Sanford Guide to Antimicrobial Therapy. Sperryville, V; 2021.

5&nb= sp;       Seidelman JL. et al. Serious superficial incisional surgical site infections (SSISSIs): A proposed surveillance definition. Infection control and hospital epidemiolo= gy: the official journal of the Society of Hospital Epidemiologists of America. 2019; 40(11).

6&nb= sp;       Shah J. Hyperbaric oxygen therapy. The journal of the American College of Certif= ied Wound Specialists. Apr. 2010; 2(1):

7&nb= sp;       Smith CM. Debridement for Surgical Wounds. Critical care nurse, 2015; 35(4):75–6.=

8&nb= sp;       Molnar JA, Vlad LG, Gumus T. Nutrition and Chronic Wou= nds:  Improving Clinical Outcomes. Plastic and reconstructive surgery. 2016;138( 3S): 71S.=

9&nb= sp;       Nascimento LD. et al. Clinical and microbiological profile of diabetic f= oot ulcers infected with Staphylococcus aureus in a regional general hospital in Bahia, Brazil. The international journal of lower extremity wounds, p. 153473462110507, 6 nov. 2021.=

10&n= bsp;   Neaman KC, Hansen JE. Analysis of complications from abdominoplasty: a review of 2= 06 cases at a university hospital. Annals of plastic surgery. 2007;58(3): 292–= 98.

11&n= bsp;   Robert N. Negative pressure wound therapy in orthopaedic surgery. Orthop Traumatol Surg Res= 2017 Feb;103(1S):S99-S103. doi: 10.1016/j.otsr.2016.04.018. Epub 2016 Dec 30.

12&n= bsp;   Negut I, Grumezescu V, G= rumezescu AM. Treatment Strategies for Infected Wounds. Molecules. 2018; 23(9):<= /o:p>

13&n= bsp;   Gao J. et al. Negative pressure wound therapy for surgical site infections: A systematic review and meta-analysis. Journal of advanced nursing. 2021; 77(= 10):

 

MODALIDATY: HEALTH PROFESSIONALS FOR CLINICAL WORK=

 

409402 - = ADVANCED WOUND HEALING WITH APPLICATION OF PRODUCTS WITH DIVERSIFIED PROPOLIS

Claudia Rodriguez1 * Adrian Marichal1 * Adrian Ramos1 * Carla Burguez1<= /sup>

1 Wound Unit RAP (Prima= ry Care Network) Canelones ASSE (State Health Services Administration) City Las Piedras, Uruguay

Introduction: In the understanding that we have in our country the industry and t= he raw material of elaboration of products derived from propolis, based on the evidence published in scientific articles that refer to the anti-inflammato= ry activity of propolis which is linked to the ability of its constituent polyphenols (flavonoids and aromatic acids) to inhibit NF-kB (nuclear transcription factor kappa-b) and reducing the levels of inflammatory mediators, this produces a decrease in inflammation, pain and microbial loa= d, it is then that for this reason it was decided to clinically verify the efficacy of this product in complex wounds by conducting a descriptive, prospective crosssectional study. Objective:= Demonstrate the efficacy of this active in controlling bacterial load, immunomodulation, pain, and wound healing. Methods: Descriptive, Prospective with cross-sectional. The method that will be used is the observation and assessment of the users, collection of data from the electr= onic medical record, individualized assessment instruments for each wound, wound measurements (MOWA, ACETATE) and EVA as a pain scale. Tolerance test. In= clusion criteria: Users who present Venous Ulcer, Pressure Ulcer and Diabetic F= oot. Results: The study began on 2/1/2019, a cut is made on 1/6/21. Total= 30 months. To date we have total patients 163 is broken down as follows: Abandonments because external reasons 5 users. Allergies 9 users. Deaths 11 (Cancer, Stroke, AMI, COVID) Referrals to Second Nivel of Care 8 users. Num= ber of Completed Patients 130. Conclusion: So far we can say that if it is clinically verifiable the effectiveness of the products with propolis reduces pain, inflammation and therefore favors heal= ing with a humid environment. It was possible to verify with practical scientif= ic evidence the different combinations and uses of the products. The combinati= on of Propolis Dressings with propolis in 2% Ointment has allowed to maintain a humid environment since the dressing absorbs the component and keeps the wo= und moist and in turn does not allow adhesion to the tissues in formation of the wound and therefore does not produce pain. In addition to the effectiveness against biofilm that was demonstrated by laboratory wound cultures. The combination of Calcium Alginate dressings moistened in Propolis Lotion has favored in the prolonged release of propolis in the bed does not allow adhe= sion because it is gelled and is also used under Unna boot therefore its change allows us to space up to 4 days. The use of Corticodre= ss dressings has allowed us to lower hypergranulation and in some cases when propolis produces pain in combination with Propolis Ointment it has allowed us to lower the pain and be able to act on the biof= ilm together.

Keywords: Propol= is; Pain; Inflammation; Immunomodulation; Cicatrization.

________

REFERENCE

1- Pharmacological bases of the topical therapeutic use of propolis in burns (Q) and chronic ulcers (UC) of the skin. Dr. Newton Ross, former Associate Professor of Medicine and former Adjunct Professor of Pharmacology and Therapeutics. University of the Republic. Montevideo, Urug= uay.

2- Leoni H, Artero G. = Perafán M. The VJ Tower. Use of non-stick dressings i= n the healing of wounds and areas that give and receive skin grafts. Argentine Journal of Plastic Surgery 2007

3-Leoni HT, Duh MN, Olivero Vila F, Yohena R. Use of topical immunomodulators in vasculitic ulcers. Revista Argentina de Cirugía Plástica 2011;17(2):76-81.

4- Kumazawa S, et al. Studies of the constituents of Uruguayan propolis. J Agric Food Chem 2002;50:4777-82.

5- Marinel.lo Roura J, Verdú Soriano J (Coord.). National Consensus Conference on Lower Extremity Ulcers (C.O.N.U.E.I.). Consensus document 2018. 2nd ed. Madrid: Ergon; • Polit, Denise. Scientific Research in Health Sciences, Intera= mericana McGraw Hill.

 

388016 - = CLINICAL PARAMETERS FOR ASSESSMENT SKIN OILINESS IN SURGICAL PATIENTS

Karla P. P. dos Santos1 * Suzinara B. S. De Lima1 * Lidiana B.T. D. Silveira1 * Bruna R. Pozzebon1 * Rhea S. de Á. S2 * Thaís D. Eberhardt= 3

1 Universidade Federal de Santa Maria

2 Colégio Politécnico da Universidade Federal de Santa Maria

3 = Universidade de Passo Fundo

Objective: To evaluate the skin oiliness of the cutaneous sites (heel and inste= p) of patients in the operating room. Method: This is a secondary analy= sis of a randomized clinical trial (RCT) carried out at a university hospital in southern Brazil from March 2019 to February 2020, with patients undergoing elective cardiac and gastrointestinal surgery. The variable oiliness was collected at the beginning of surgery - baseline, measured in the center of= the heel and instep, using a bioelectrical impedance skin analyzer and the measurement was given in percentage (%). The analysis was performed by protocol, with the aid of the Statistical Package for Social Sciences (SPSS) version 21 software. A descriptive analysis of the data was performed, the normality of the variables was tested using the Shapiro-Wilk test. To assess the relationship between skin oiliness and skin sites, the Wilcoxon test was performed (absence of normal distribution, paired data). To assess the correlation of skin oilinesss between cutaneous sites, Spearman's test was performed. Values of r from 0.90 to 1.00 were considered a very high correlation; high from 0.70 to 0.90; moderate from 0= .50 to 0.70; low from 0.30 to 0.50; and insignificant from 0.00 to 0.301. A significance level of 5% was considered. The study was approved by the Et= hics Committee with a Certificate of Presentation for Ethical Review 77103617.6.0000.5346 and registered on the platform of the Brazilian Regist= ry of Clinical Trials (ReBEC), being approved unde= r the identifier RBR-5GKNG5. Results: One hundred and = thirty five patients were analyzed, 270 heels and 270 insteps, with 91 (67.= 4%) patients undergoing cardiac surgery and 44 (32.6%) gastrointestinal; the majority (n=3D107; 79.3%) had some comorbidity. The median of skin oiliness= on the heel (22.6%) and on the instep (29.2%) showed a statistically significa= nt difference (p-value <0.001) and a low positive correlation (r=3D0.339; p= -value <0.001). Conclusion: It was identified that the oiliness of the h= eel is lower than that of the instep. Furthermore, the correlation is positive between the cutaneous sites, that is, the greater the heel skin oiliness, t= he greater the instep skin oiliness. In this sense, the nursing team can use t= he instep oiliness as a comparison region for the heel oiliness. It is notewor= thy that the skin oiliness can reduce the skin tolerance to external forces suc= h as friction, favoring the development of pressure injuries2.

Keywords: Perioperative Nursing. Pressure Ulcer. Skin. Heel.

 

REFERENCE

1. Mukaka MM. A guide to appropriate use of Correlation coefficient in medica= l research. Malawi Medical Journal. Sep 2012; 24(3):69-71. Disponível em: https://www.ncbi.nlm= .nih.gov/pmc/articles/PMC3576830/. Acesso em: 20 jul 2021.

2. Bunsell AR. (Ed.). Handbook of Properties of Textile = and Technical Fibres. 2nd. ed.2018.

------=_NextPart_01D7EA15.3E0692F0 Content-Location: file:///C:/E87559EC/RESUMOSSGWACm2021GANHADORESHTML_arquivos/themedata.thmx Content-Transfer-Encoding: base64 Content-Type: application/vnd.ms-officetheme UEsDBBQABgAIAAAAIQDp3g+//wAAABwCAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKyRy07DMBBF 90j8g+UtSpyyQAgl6YLHjseifMDImSQWydiyp1X790zSVEKoIBZsLNkz954743K9Hwe1w5icp0qv 8kIrJOsbR12l3zdP2a1WiYEaGDxhpQ+Y9Lq+vCg3h4BJiZpSpXvmcGdMsj2OkHIfkKTS+jgCyzV2 JoD9gA7NdVHcGOuJkTjjyUPX5QO2sB1YPe7l+Zgk4pC0uj82TqxKQwiDs8CS1Oyo+UbJFkIuyrkn 9S6kK4mhzVnCVPkZsOheZTXRNajeIPILjBLDsAyJX89nIBkt5r87nons29ZZbLzdjrKOfDZezE7B /xRg9T/oE9PMf1t/AgAA//8DAFBLAwQUAAYACAAAACEApdan58AAAAA2AQAACwAAAF9yZWxzLy5y ZWxzhI/PasMwDIfvhb2D0X1R0sMYJXYvpZBDL6N9AOEof2giG9sb69tPxwYKuwiEpO/3qT3+rov5 4ZTnIBaaqgbD4kM/y2jhdj2/f4LJhaSnJQhbeHCGo3vbtV+8UNGjPM0xG6VItjCVEg+I2U+8Uq5C ZNHJENJKRds0YiR/p5FxX9cfmJ4Z4DZM0/UWUtc3YK6PqMn/s8MwzJ5PwX+vLOVFBG43lExp5GKh qC/jU72QqGWq1B7Qtbj51v0BAAD//wMAUEsDBBQABgAIAAAAIQBreZYWgwAAAIoAAAAcAAAAdGhl bWUvdGhlbWUvdGhlbWVNYW5hZ2VyLnhtbAzMTQrDIBBA4X2hd5DZN2O7KEVissuuu/YAQ5waQceg 0p/b1+XjgzfO3xTVm0sNWSycBw2KZc0uiLfwfCynG6jaSBzFLGzhxxXm6XgYybSNE99JyHNRfSPV kIWttd0g1rUr1SHvLN1euSRqPYtHV+jT9yniResrJgoCOP0BAAD//wMAUEsDBBQABgAIAAAAIQAt LgC8nAcAAMsgAAAWAAAAdGhlbWUvdGhlbWUvdGhlbWUxLnhtbOxZzYsbyRW/B/I/NH2X9dWtj8Hy ok/P2jO2sWSHPdZIpe7yVHeJqtKMxWII3lMugcAm5JCFve0hhCzswi655I8x2CSbPyKvqlvdVVLJ nhkcMGFGMHSXfu/Vr9579d5T1d3PXibUu8BcEJb2/Pqdmu/hdM4WJI16/rPZpNLxPSFRukCUpbjn b7DwP7v361/dRUcyxgn2QD4VR6jnx1KujqpVMYdhJO6wFU7huyXjCZLwyqPqgqNL0JvQaqNWa1UT RFLfS1ECamcg4y2Y93i5JHPs39uqH1OYI5VCDcwpnyrlOJcxsIvzukKIjRhS7l0g2vNhpgW7nOGX 0vcoEhK+6Pk1/edX792toqNciMoDsobcRP/lcrnA4ryh5+TRWTFpEIRBq1/o1wAq93Hj9rg1bhX6 NADN57DSjIuts90YBjnWAGWPDt2j9qhZt/CG/uYe536oPhZegzL9wR5+MhmCFS28BmX4cA8fDrqD ka1fgzJ8aw/frvVHQdvSr0ExJen5HroWtprD7WoLyJLRYye8GwaTdiNXXqIgGoroUlMsWSoPxVqC XjA+AYACUiRJ6snNCi/RHOJ4iCg548Q7IVEMgbdCKRMwXGvUJrUm/FefQD9pj6IjjAxpxQuYiL0h xccTc05Wsuc/AK2+AXn7889vXv/45vVPb7766s3rv+dza1WW3DFKI1Pul+/+8J9vfuv9+4dvf/n6 j9nUu3hh4t/97Xfv/vHP96mHFZemePun79/9+P3bP//+X3/92qG9z9GZCZ+RBAvvEb70nrIEFujg j8/49SRmMSKmRD+NBEqRmsWhfyxjC/1ogyhy4AbYtuNzDqnGBby/fmERnsZ8LYlD48M4sYCnjNEB 404rPFRzGWaerdPIPTlfm7inCF245h6i1PLyeL2CHEtcKocxtmg+oSiVKMIplp76jp1j7FjdF4RY dj0lc84EW0rvC+INEHGaZEbOrGgqhY5JAn7ZuAiCvy3bnD73Boy6Vj3CFzYS9gaiDvIzTC0z3kdr iRKXyhlKqGnwEyRjF8nphs9N3FhI8HSEKfPGCyyES+Yxh/UaTn8Iacbt9lO6SWwkl+TcpfMEMWYi R+x8GKNk5cJOSRqb2M/FOYQo8p4w6YKfMnuHqHfwA0oPuvs5wZa7P5wNnkGGNSmVAaK+WXOHL+9j ZsXvdEOXCLtSTZ8nVortc+KMjsE6skL7BGOKLtECY+/Z5w4GA7aybF6SfhBDVjnGrsB6gOxYVe8p FtjTzc1+njwhwgrZKY7YAT6nm53Es0FpgvghzY/A66bNx1DqElcAPKbzcxP4iEAXCPHiNMpjATqM 4D6o9UmMrAKm3oU7Xjfc8t9V9hjsyxcWjSvsS5DB15aBxG7KvNc2M0StCcqAmSHoMlzpFkQs95ci qrhqsbVTbmlv2tIN0B1ZTU9C0g92QDu9T/i/632gw3j7l28cm+3j9DtuxVayumancyiZHO/0N4dw u13NkPEF+fSbmhFap08w1JH9jHXb09z2NP7/fU9zaD/fdjKH+o3bTsaHDuO2k8kPVz5OJ1M2L9DX qAOP7KBHH/skB099loTSqdxQfCL0wY+A3zOLCQwqOX3miYtTwFUMj6rMwQQWLuJIy3icyd8QGU9j tILTobqvlEQiVx0Jb8UEHBrpYaduhafr5JQtssPOel0dbGaVVSBZjtfCYhwOqmSGbrXLA7xCvWYb 6YPWLQElex0SxmQ2iaaDRHs7qIykj3XBaA4SemUfhUXXwaKj1G9dtccCqBVegR/cHvxM7/lhACIg BOdx0JwvlJ8yV2+9q535MT19yJhWBECDvY2A0tNdxfXg8tTqslC7gqctEka42SS0ZXSDJ2L4GZxH pxq9Co3r+rpbutSip0yh54PQKmm0O+9jcVNfg9xubqCpmSlo6l32/FYzhJCZo1XPX8KhMTwmK4gd oX5zIRrB3ctc8mzD3ySzrLiQIyTizOA66WTZICESc4+SpOer5RduoKnOIZpbvQEJ4ZMl14W08qmR A6fbTsbLJZ5L0+3GiLJ09goZPssVzm+1+M3BSpKtwd3TeHHpndE1f4ogxMJ2XRlwQQTcHdQzay4I XIYViayMv53ClKdd8zZKx1A2jugqRnlFMZN5BtepvKCj3wobGG/5msGghknyQngWqQJrGtWqpkXV yDgcrLofFlKWM5JmWTOtrKKqpjuLWTNsy8COLW9W5A1WWxNDTjMrfJa6d1Nud5vrdvqEokqAwQv7 OaruFQqCQa2czKKmGO+nYZWz81G7dmwX+AFqVykSRtZvbdXu2K2oEc7pYPBGlR/kdqMWhpbbvlJb Wt+bmxfb7OwFJI8RdLlrKoV2JVxbcwQN0VT3JFnagC3yUuZbA568NSc9/8ta2A+GjXBYqXXCcSVo BrVKJ+w3K/0wbNbHYb02GjReQWGRcVIPszv7CVxg0E1+c6/H927vk+0dzZ05S6pM38pXNXF9e19v WLf32U28N1OX875HIOl82WpMus3uoFXpNvuTSjAadCrdYWtQGbWG7dFkNAw73ckr37vQ4KDfHAat cafSqg+HlaBVU/Q73Uo7aDT6QbvfGQf9V3kbAyvP0kduCzCv5nXvvwAAAP//AwBQSwMEFAAGAAgA AAAhAA3RkJ+2AAAAGwEAACcAAAB0aGVtZS90aGVtZS9fcmVscy90aGVtZU1hbmFnZXIueG1sLnJl bHOEj00KwjAUhPeCdwhvb9O6EJEm3YjQrdQDhOQ1DTY/JFHs7Q2uLAguh2G+mWm7l53JE2My3jFo qhoIOumVcZrBbbjsjkBSFk6J2TtksGCCjm837RVnkUsoTSYkUiguMZhyDidKk5zQilT5gK44o49W 5CKjpkHIu9BI93V9oPGbAXzFJL1iEHvVABmWUJr/s/04GolnLx8WXf5RQXPZhQUoosbM4CObqkwE ylu6usTfAAAA//8DAFBLAQItABQABgAIAAAAIQDp3g+//wAAABwCAAATAAAAAAAAAAAAAAAAAAAA AABbQ29udGVudF9UeXBlc10ueG1sUEsBAi0AFAAGAAgAAAAhAKXWp+fAAAAANgEAAAsAAAAAAAAA AAAAAAAAMAEAAF9yZWxzLy5yZWxzUEsBAi0AFAAGAAgAAAAhAGt5lhaDAAAAigAAABwAAAAAAAAA AAAAAAAAGQIAAHRoZW1lL3RoZW1lL3RoZW1lTWFuYWdlci54bWxQSwECLQAUAAYACAAAACEALS4A vJwHAADLIAAAFgAAAAAAAAAAAAAAAADWAgAAdGhlbWUvdGhlbWUvdGhlbWUxLnhtbFBLAQItABQA BgAIAAAAIQAN0ZCftgAAABsBAAAnAAAAAAAAAAAAAAAAAKYKAAB0aGVtZS90aGVtZS9fcmVscy90 aGVtZU1hbmFnZXIueG1sLnJlbHNQSwUGAAAAAAUABQBdAQAAoQsAAAAA ------=_NextPart_01D7EA15.3E0692F0 Content-Location: file:///C:/E87559EC/RESUMOSSGWACm2021GANHADORESHTML_arquivos/colorschememapping.xml Content-Transfer-Encoding: quoted-printable Content-Type: text/xml ------=_NextPart_01D7EA15.3E0692F0 Content-Location: file:///C:/E87559EC/RESUMOSSGWACm2021GANHADORESHTML_arquivos/header.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="windows-1252"





https://doi.org/10.31011/reaid-2021-v.95-n.36-art.1272  Rev Enferm A= tual In Derme  v. 95, n. 36, 2021  = e- 021172         =                    1

 

------=_NextPart_01D7EA15.3E0692F0 Content-Location: file:///C:/E87559EC/RESUMOSSGWACm2021GANHADORESHTML_arquivos/image001.jpg Content-Transfer-Encoding: base64 Content-Type: image/jpeg /9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAMCAgICAgMCAgIDAwMDBAYEBAQEBAgGBgUGCQgKCgkI CQkKDA8MCgsOCwkJDRENDg8QEBEQCgwSExIQEw8QEBD/2wBDAQMDAwQDBAgEBAgQCwkLEBAQEBAQ EBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBD/wAARCACWAXIDASIA AhEBAxEB/8QAHQABAAIDAQEBAQAAAAAAAAAAAAYHBAUIAwIJAf/EAFIQAAEDBAECAwUEAwkLCgcA AAECAwQABQYRBxIhCBMxFCIyQVEVYXGBFyMzFhgkN0JSV3S0CTU5SGJ2gqGlstMmNHKFkZKVtcTS OGNzdYSxs//EABsBAQACAwEBAAAAAAAAAAAAAAABAgMEBQYH/8QANREAAQMDAgMFBwQCAwEAAAAA AQACEQMEIRIxBUFRImFxgZEGEzKhscHRFBVC8CPxB5Lhsv/aAAwDAQACEQMRAD8A/VOlKURKUpRE pSlESlKxJd1tkBXTOuMaOenq066lB6d+vc+n31IBOAkwsulY0a4QJqUrhzWJCVhRSptwKCtHR1r1 0e1ZNQRG6JSlKIlKUoiUpSiJSlKIlKUoiUpSiJSlKIlKUoiUpSiJSlKIlKUoiUpSiJSlKIlKUoiU pSiJSlKIlKUoiUpSiJSlKIlKUoiUpXytaGkKccUEpSCpSidAAfM0RfVU7yL4j8WxSPMRj7rFzcgu FiTNUv8AgTD+t+SFDu+96fq2/QbK1IA3VS5dzTlfPGbS8d4yySdjnHWJymzeMjgLLcm6SUnqTFir /wArW+3bp99fZSEL3d3xHjLNoqshy/AmordvdCI5tcpyKh9allxTXkg+USralOLCQo79dkVyKvtL wfh1620v3kEguOkTAGcxtPL/ANE6tVtzcUXVLSIGJPPw/vgv5Lz+68ux7NlN1y/J8JsZ2TYYgQhF 1UhWw8qU10yERyfdUjXv6OjrZMe5stOf37CHpOItWnKrnepYjoW4GApuMghbqemWE7SSG0dIPbYI PapmnHcYy65pbtWRy4kl0BLceZBHQhCR2SlTStJQlI7e6AAPlXnebA7k8llGJXWz3ODEaTHhxos9 vzUtjfdTailXWpRKj29Sa9vwjjvBbvQ+xuGETsYG0GMwScjnkb8lwLineQTVaT0jc9+JHywufeF8 EzW8ci2/jLk3imTYbJeS66qfbWH4hjSmmVrbeZkNLLKF+70kD4gdEHQq+MRazrHssk8UWXO+Q7VJ jmR9jSsqt7Nzgvls9QSmSPLW60tA2EK0pOtJcBGjucdt+UYbjOT3uVDuMSWzFREhtlCwQ46dFxI9 PdHfq+896jtk5z5Bs4S0/cGrk2jt0TGgpX/eTpR/MmuveNq31R7qYaQABvjVvInUNiAR81a3qtoM b7yQTny2jkeRVtYJyjd5TUq28gsWhi4QVFKpNqdcLLwB0olh39ayoH1RtwfMKPoLHjSo01hEqG+2 +y4OpDjagpKh9QR61zpy3dePcezGLGySVcrPPu8Ju5LmMNCRGbcUVJUFIGnE90b2kK9fSrDwLJmT Y4l1sqI+QtyZyIdxlWiUFpQCjaZKmDohY2gOJ0F6PUQQK8/d2dM0216OJ5HbyOx/uF0bW9earqFU gx038xv/AHdWdSvCJLjzmEyYriVoUSNj5EHRB+hBBBH1Fe9cjbBXW3SlKURKUpREpSlESlKURKUp REpSlESlKURKUpREpSlESlKURKUpREpSlESlKURKUpREpSlESlKURKUpREpSlESq+5Jyi5ouFuwn G22X7jc1gvoebDjYYOwUrSe3Sob6v8kH61YNQa2Yc6zmGQ3qZemHLhObCYZR3cjMK7bKD6a6QkH5 9J+pA4XH23tag23sgQXuhzmkAtaASYJOC6NIOwJkkLesDRY91WtB0jAOxOwnuEyfBaSJwlx7Gx9u x4W4zZocFx50R4SuuO284oqcUUqJUNq3rauyQANAAVH8gwa53j2djF59smwITflRozUkJe+qlrSr Q6lHue/0HoBUxvjTWD4qbQw+HJtyWoLcA0Sj5n/s0PzNQe1QHrrcY9vjnS33AkK/mj1KvyAJ/Kvj 3tNxejSvadpUtAbmqG+9DXkHUT2WA9oTEF2CCdPRbVGxbWontQwbYxA7voo7lFvvuCYPOkyLVKau V5Uq3hXlEiLFGi8tShsAr2lA2e4KiKpTe/T512PKvUpiUU22U61HZSGWkhWx0JGgTv1361hPRMau K3rvkeMWeULe2qY5JVEQl4dHvABY1vZHoex9K51rx/g15dN4Xbue2DpaYDmnOXFwIMHedOGxMALQ r8GruGtpHhzUJZm3zB7NZcZiXWUzLgxvOnHzCf4Q775bIOwQgFKdenY/fXsMhYyCU0xkOJ2m7vvO JSl0s+S+pRPYeYjR9furDeyPBshkuzbj9q2iXJWVuL92Uz1E7J/kq/1Gt9iWONquQvdiusG9twG1 yEMsLKHi4lJ8sKQsAp2rXf7q6Flf8ZfxT3nCbkhjnADQ+YaIAlhh3ZaMksW3ccNqW1PTcUjA6iR6 5HzUR5nxDCOUsrkSVZdKsd6t6Ps9PtTAdguhtStAFHvN+8pW1HY9O1aTFsEzHjLAckXcZDCENXO3 zLVcrdMS42+rTrbhbUk9Q0CnfUB6+hr4u9tvFtmLTeoMmNIcUVHz2ykqJOye/r+IqYceTDZMYyi/ PR2JLLbTEdMeQnqaeUtfcKT6Ht/+6+hcA/5L4gLr9FxCmDTEnaHNa0FxnrgRkBeWq8LoPqm4bh+c 8siMj8QtpxRysiTe2oGRSmIzt4dEcK10NyJmtpV9EuLSOkgaCiE679jelcecsYjAzHjbJLpxnCmx bzAZZuZtDSypxC2H0OB6Mv1PT09RT8XYhIOwD0rxPm7PJHG2OZwyoE3e3tPPAa0l4DpdT2+jiVj8 q+l1bix4pas4nw14dTcYPcQJgjlzx3LLZPqMJoVdxkHqP79VLqUpWiuglKUoiUpSiJSlKIlKUoiU pSiJSlKIlKUoiUpSiJSlKIlKUoiUpSiJSlKIlKUoiUpSiJSlKIlKUoiUpSiJX5J+IPkzK8y8S2RX /E71cI8xi5/Y1pchSFtOJbZV5SA2pJBHUtJV6+qzX6ZcyZHfcUwxN8x6QlqW1dLc0StAUlTbsptp aVA/IpWR20foRVHyvAThtr5VsfJeFZFKjR7deGrrJtE8ee24ptzzAlt7fWkdQT2WF+p7/KuRxKnU uiKNLlBPnIEeEFe19kb+z4Oal3ebuaWtxIkQSD0mRHnMKmc+8X/KvF/Is/BbZdbdk1nxppiyvpvM UPqlymGkokvKdT0uFS3g56qI0B29d2rx94usLmcdXXlLN+O5GPR4E+PYUP2l4SPapEhK1r8ttfQE 9DaOpWyT0ntv0rmjk/wp+ImwXS45DeMJfvKZch2W/Ls6xLSpS1FSj0J/WDuSe6BWPzTCkYTwtxXx u7Hdiy50abllzZcSUqLslzymCpJ9Clpop7/U1wats2vVc+8pAxMamiROBBIkRPIhfUb3gHs9xCzt 6NjodUcWtL6bs9lpc4kNMEnTHaG7l21inNXBeedCMV5Xs4kOAdMS5KMF7qP8kB0J6j/0d1JeQLXf 4uGmDa7a/LXcH0qkORkeaEsI0oDt395XSfwSa/KLEcWn5pldnxG1p3LvM5mCyddgpxYSCfuG9n7g a6s5h5UyHGeS3LDxtk1xtFow+IxjsFESUpCFNxkhKupI91fvhXqD2Arx9b2L4DY6ry2Y6m4gsGl0 gahDiA6T8Mj4tneC8rfezD7K9p0aFTVguhw2giMiNycY5KxFtraWW3UKQtJ0pKhog/eKtbGm14jx k5ckKUzcMgfCWlpOlpZT6EEdx6K/74qjuJvEFyVyJmVmwTJ7LYcnRcpCWnJEuCG5DLIG3HAtrpA6 UBR+H5VdT/LPC2WSRj1xmTrMi1rXEhSCncdbaToKSR1aB6R8QHbXeuTa+zX7bTrV7W4aaj2llPV2 CCYDjOQCGEgdrcjZaHE23Rc23q0iQCHO09rGY6HJHTkveFyHdzH+z77EjXuGrsWpbYKvyVr1+8g1 PJfGdiuGLLsUNp60IlPpnKQ2vr8t7p10nfxJH02PyrQY5x3BkXWDerVkMC72ltwOqcZWFEkd0j3S UnvrfcfhUf8AETe+RLPeLDLxNFwiw42/4XH7oXIcUEpbWO41oDQUNHrPrXc9nLXiXDuHXFx7RsdV aIY0GHO0n4iHiTpgiO1GCvMXdrbcSu2W9rDSQZJxnkCOvlKgfNmP3fi/hvOJFxeQh2cmDAgPsr/a qVJQtRT80kIQo/iPzqb+DDI15Lw+qZJQlEoXaUXwlQ6VuK6VqcSkfCFqUpRHp1FZHrUy5L45tHKH G8bAeQrm03cpyEFiU1pspuCGyQ42nela9/afmkn07EV94PcWu+EWzKMLvTSW5thmtRZSULC0+ctH mkhQ7EdC2z+Cvyr6LwixZwqmLa2kU8kgnMk6oPeJgd3PdeMqUalK9Dv4kEA+BXRNKUrtLdSlKURK UpREpSlESlKURKUpREpSlESlKURKUpREpSlESlKURKUpREpSlESlKURKUpREpSlESlKURKUpRFD+ XLLMv3HV6gW9gvS0NIlx20jZW4w4l5KR95LYA+81EuGOPsywzOeSr5f5SXrRld2au1nSmSpflIX5 qnEKbV+zWOpAOux16nVWvJjMTIzsOU0lxh9CmnEKHZSVDRB+4g1E+OnlWazx8GuUhxc+yeZBaU4k 7fjNdPkub7ju0tr1O9hX0Na7qLTWFU7/AIn8ldS3va1Oxq2rILXROMxLTI6QWgHuKkca5PSLrNti rVMZbhtsrRLcSkMyCvq2lsg7JR0jq2B8Sdb76pTlfNGV5ZOx694tYMgtcYNpEa6QEPgEtgq0T6d1 VILN4oOH7tlz2Ayr5KtGRM3BVr9guMNxpS5AcLYSlYCmztQ7e93BFYOd8RXG/wCUzbjbcgtpkzNP iG+oocCNBO+29jse+gK8r7Y/ulWwZ+zEl4eCdJExBxHPMYyt7gzaFrdar0aRpxM74yD65Vf4Xivh 8s18k8st8Yt43LwuBKvL0mDLWqOEJbUFaYJ6OrSlFIA9QKplPHfBnJMhU/jjxE2lM+apTpgZM2YT 5cUdkFxWgo7J+FJq5uVeOc8x/wAPnIdtt2OTrlebw3Ehxo9uR7Q44z56S6oJRtWugr323oelfm7c LDfLVOFsutmnQphUECPJjrac6ida6VAGuVYG7q8Opfu9Oah1EyNJGYG0CYE5B3X0Xgtt+5vq16N0 4FpDR2g/sgT/ACkxLjsRzXfvHHBef8VY9mGVS7Mm4XaVBRa7Mu1rEoFp4/wh9PT7w0gBIOge5+Xe qvkxJUJ5UaZHdYdQfebdQUqH4g9xXdXDeCs8Z8XYzgzKNKtVuabfP86QodbyvzcUs/nW4yrH8cvd qknILBCubbLK19EhpKj2BPuq1tJ+8elbvFPY39wYw0amktGxEiSZOceExsAvK2/tkbW4qmszWCfi GDAwMGekxO5KrDwvYMcfw9zKpjREy/KCmwf5MZBIR2/yj1K/Dpq6SkKGiAR9DVCYXzlyfkWCQsux Tw9ofx/yVpjhjKGfN8plamlBLSmQSQW1AD1Ou29itxf/ABGwY/GWLckYji670Mqu7NmYgvzUxFsv rDoIWvpWNhbRT6aIV1b16+z4bwZ3DLWnZsA7ODkb7mc4kycrwvEONU+JXL7t5PayMH4dhGMwI2Ug 5EwK9ZflmMzWpoTarc+VyW0q6FtkHq6wfnvpSnt3Hr8zqVWPFoFhul9u0T9rf5qJ0gdIAC0sNtfn 7rQqI2TNeaJt3hw71wjEtsB55KJExOVMvlhsnusNhoFeh8gRuszBeUP3X5nmODzrILXccSlttdJk +b7VHcBU0+B0J6dpAJT72uodzsValw5tvUqV25LoJyDtAH971WpxD9QylRfgNkNwRvJO43/CnlKr 25crmNyqrjG3Y+ZhiWNy93Cd7V0CKkEhDfR0HqUo9HfqGgrejoitdYue7JM4Nb5wyG0u2yEpt5So TTwkOdaJK2EISopQFFakj1AA6u/YE1t+4qQDG8fPb6LX/U0pInaZ8on0kK06VU1u5syGFklksfJH F83E4+TPCLaZqri1LSuQRtLLyUAFlatgAHfc6+RIwuS+aOTuNLbeckuXC0d/H7VI8tM9OTtJU80p 4NNOeSGSpPUVIPT36d9z23Ui2qFwaIk7ZGfmqm7pBpeSYG+DjnnEhXNSoHg2Ycm5DcEJyviqPj1t djl5uajIGppKjrpR5aW0kbBJ3vtr071Gsb8Q8LIeXJHGqcZXHgGVOt8C8mZ1ImS4iELfaS30DWgs 9+s+g7d+0ChUMwJgScgqTc0gASYkwJBH1CuGlKVhWwlKUoiUpSiJSlKIlKUoiUpSiJSlKIlKUoiU pSiJSlKIlKUoiUpSiJSlKIlKUoiUpSiJUY5BvGRYri1xyjEMR/dJc4TaXl2xp7yX5jKDtaGlEEF0 JKihJ7KPu7G91J6USYXBTPHVg8VWVK8R3A2eQ7TKN2YRJsGQRFRpEa6RkoUUKUhS9FQQlegkj4jv sQJl42+GeUc4yDGc54/xmXc3YduXDnIgPJ86OpK+tBSCUqWD1rG0gn3fQbFZXiO8G8PILhkGccd2 1t6Lk6Q9luNtrLS5b7W1NXO3LAIZuDaiohJHlvBS0q11qK/H+5+p5MxzHLxhF7yq25xiMaY8u23u POcE21yEqCXbfOhyUokR3O3WEKSeglQ2pKkqrE6gx4II3WzTuqtJzXtdkbK0/B+/k/6FYVqzKJeI 15tU6XEkt3ZDqZCf1hWnYd97p6VpA+XbQ9Kt652az3ptDN5tMOe22oOIRJYS6lKgdggKB0QQDus6 lXawNaGrE+q59Q1dicpWFev7zT/6q7/uGs2vGVHRLjPRXCoIeQptRT6gEaOquMFYiJELkviC6+IK zeGuHc8Bg4a7aYcO4PRlPuSTcelMl4uENgBorCuspHVogJ3s9qZra7Va/Dnw8xx65tt7LbXJiLuK d7lOJkrUXgg+gdJBCT6DQPoauzGXuGuHcUZ4kk8i2Zhm2IdbcjXm8Rm5XS+tTxDido1sO9vdHuke vqYaMN8P9+wTGuIbfzay4zZbs3OtDkPIoBnqklTnltpISQr3nz0gI6thIB7V1RXDnl+mBqnbcZ3/ ALzK4hty2mKeoE6Y3GDjA9PkFYGLt8+JvsY5rMwBdm9/2lNrjTUyj7iujoLiyge/072Ph3rvUQzF IwHxJ4pmIX5Vuza3vY9PV1AIElvTjClb+avdQD9En8/WLi+F4zl8K23LxN5U5dokyOr7GuOVQ+p9 ZUlSGXGPLC1BwFI6RoqCu3qKl3MuF4Pm2HeyZ/f12O2W+YxOTc0y2oqoryVdKFB10FKdlfT3Hfq0 O+q1g4NqCdiIwI3+q2y1z6Rj4mkHJnbv5dFA+D2jlLHI3M0lPUcsnyI9tcUDv7NipU0zr6bIOwP5 g/KOcW27BL54ObDjvIt3Ra7VdnJUVMpSuktyPtB9TRSSCArqRvv2OiD61dGNNcfYpxfBh2jJICcU gQBFbui5zRZU38BcU+P1ZUVE7I0OonsPSoHao/hntvFbfDsvk7Gbpj7SXUj23IYhfJW8p7q621JA Ula9ggD0Hr33f3uomAfiERyABHqMLH7nQGyR8Lpk4JcQfQ5WnmXXlTha+4nbOQr5as6xO63ePaIk 56EGbjBkr2GVkdwvQBJVtSj0nuCRuTeLv/4eMs//AAf7cxWJivH/AA1GVGzx7lmXlltxV0GI/dsl ZmQLU7pISQU6QlYBTorJI93XfVbbkbKOCOTsNuGD3/l7G48C5eT5rkO/w0vDy3UOp6SoqA95A3tJ 7b/Gmoe9Y8DY5gRz6JpPuKjC4doGATPKN+krfZzmjHHvEdwzF1aUqttpStjq1pT6kBLSe/1cUgfn XLVxtvJ+CcT4Xf5HE82ErCbsjIpN8Xd4rypKH3NupUylXmAL62kn1ICPeHqR0bmlt4l5WwFuHcOQ YLmMWWZHemSoN1ilhSmgOlqQ6QpASSpJI90k9PcfPPyDkHhPMLFcMUuXJ2JPRbvGchOobvkUrKXE lJ6ffPvDewdHRApQqe5EBs5zvt/SVNzS9+6S+OzjI33594GynFtuES7W6LdYDodizGUSGXB6LbWk KSR+IINZNR7AMftOK4ZaMcsN4kXS22+MliJLfeQ6txob6ffbSlJAGkjQHYCvOz8l8c5BcGrRYM/x u5zn+otRYd1Yeec6UlSulCFFR0ASdD0BrSLMnTkBdBrwANZglSWlYN4vVnx63u3e/wB2hWyAx0h2 VMkIZab6lBI6lqIA2SANn1IFYuP5fieWoecxXKLTeURilLyrfNakBoq3oKLajrejrf0qukxMYVtT QdM5W4pWov8AluKYm0y/lOT2mzNyFFLK7hNbjhxQ7kJLihsj6Cs6DPgXSExcrZNYlw5LYdYfYcDj bqCNhSVJJCgR6EGkGJ5KdQJ0zlZNKxLndrXZYi7jeblFgRW/jflPJabT+KlEAVgWHNcNypa28Xy2 zXhTY2tMCe1IKR9T0KOqBpImMKC9oOknK3VK1l+ybHMVhouGUZBbbPFcdDKH58tuO2pwgkIClkAq 0lR166B+laH9MvEH9KuH/wDjkX/31IY52QFDqrGmHEBTGlaF3O8HYsLOUv5nYm7LJWWmbku4siK4 sFQKUulXQo7SoaB9Un6GsmwZRjOVxnJuLZFa7xHac8px6BLbkIQvQPSVIJAOiDr7xQtcBJCB7SYB ytrStDf89wbFZLcLKMzsVmkOt+a21PuLMda0bI6glagSNgjf3GttCmw7lEYuNulsyokptLzD7LgW 262oApWlQ2FJIIII7EGoLSBJCkPaTAOVkUrykSGIjDkqS82yyyguOOOKCUoSBsqJPYADvs1qcfzX DctU+3iuW2W8qihJfTb57UktBW+kq8tR6d6Ot/Q0AJEoXNBgnK3dKis/lTi+1TX7ZdOSMWhzIyy0 9HkXiO240sdilSVLBSR9CK8P0y8Qf0q4f/45F/8AfVhSef4n0VTWpjBcPVTGlaFWd4OibbravM7E mZd2WpFvjm4shyY05sNraT1bcSrR6SkEHXbdbK63a1WO3vXa93OLb4MYBT0mU8lppsEgAqWogDuQ O59TVdJ6Kwe0yQdlmUrCtF5s+Q29q72G7Q7lAkdXlSob6XmXOlRSrpWglJ0oEHR7EEVrrhnmDWm8 N47dczsUK6uqQluDIuLLchalkBADalBRKiRoa777UDXEwAhe0CScLfUpWnx/L8Ty1DzmK5RabyiM UpeVb5rUgNFW9BRbUdb0db+lIJEqS4AwVuKUpUKUpSlESlKURKUpREqu884PxDNrlIyWK7Ox3JZM b2R682d72d+UwB2ZkpHuSWx20lwEp/kFB71YlKIqmxC3c18aWxvH7m1G5EtzDnTGuCZ/stzbZ/mu of2h3XyV5wVrsd+tTm0Xl3IJjS3rNf7O5E6lKaltJQ27tOtEoUpKtb2NH1FSClESlKURcT5fZsIv /jbvVs5DTBVZHGWS+JsnyGuoWxoo2vqTo9QGu/rV5Y1xV4XGMgt0vFoWMOXeLJbkwhGvBddDzZC0 qSgOnqIKd60fSqKzbH8FyfxsXuz8j+ymxOssqf8AaZiorfUm2MlG3EqSR7wHz71d2H8YeFbFMmt9 /wAQex9i8xXf4GtGSOPKDigUaCFPqCiQojRB9a7Fw6KbBqcOwNttvFcC1Zqq1CWsPbOTvvyx91zR 4hMWuuXeJrNLfY1OfaMWExcIyW/iWpi3sOqAO9hXQlXTrv1AD51cfIvJbHK3gvu+UeYn25KIES5I B+CU3Njhfb5BXZY+5YrVwP8ACBXL+qp/8pbquec7fK4UvOf8aR2loxfPY8a6WxISehh5uU26Uj6A dDrevXRaJ9K2ABVNGnzaGuH3/K1XE0BXq/xcXtPj/E+uPNWl/iDf9V/+vrWeH7jzw3X3iKw3TPmc bVfn/avazMu3kvdpTqUdSPNTr3AjXYdtH51s/wDEG/6r/wDX18+HTw6cNZ3w1j2V5Xh3t10ne1+f I+0ZTXX0Snm0+626lI0lCR2A9PrWFzwyk8ucR2ztv9Qs7abqlakGtDv8Y+LbfwKlPLeI8c4n4ac0 b4yiQGbXNQ28tcKSX2nHQ+0knqKldwEgdj8qgvh+488N194isN0z5nG1X5/2r2szLt5L3aU6lHUj zU69wI12HbR+dWXzjhWM8feGTKcYxG2ewWyMwhbbHnOO9JXJbUr3nFKUdkn1NVXwLxX4Zsk4nsd6 5BTZDf5PtXtftGQOxnPdkupRttLyQn9WlH8kbGj891Wk8fpnO1O+Lcb7c8/dZK1Mi7a3S34Njtvy x9lYXLWKcbYr4as2a4wjW5u2SktOuqgyjIbW6HmUk9XUruAANbqJ8E8EcL5h4f7RlWbY9HRLktTV S7oqY4wptLcp5KV9XWEJ6UoT6jXbvvvUs5Xs3G+N+GPMLBxfIt6rVFbQtTcO4GWG3FyGydrUtagT 66JqquKvCthHI/A0TODMu7GRzos5bRbeSWPNafeQ2PLKdkENpBHVvudaqabgLckvLe3vz255VarC boBtNruxty35Y/CmHgMkXpWO5dDckPPWKNPYFuUvYR5pS553SD6bT5JI+p++uYeJpsrDMjx7lBL3 RDtOQRokxR7ANuJUVDf3tpeH5V2P4K8xeybiI2qUxGadx+cuCnyWkNhbRQlaFKCQB1bUoE62enZJ JNc38R4f+7Lw8cqR2WuuTanoF2j6GyFMJdUvQ+pa8wdvr+VbNN+mrW1jBLQfPH/q1KtPVRtxTMkB xHiIMfZdBeMme/ebNhvFtscPteXX1pGk9z5SCE+n063mz/omov8A3P3+8uZ/1mF/uO1ruHMid505 wwq8yApyNgmJtGUTvpVOCSgq39StxKgP/l/PR3/fA7eoON4TyJkVzX0RLYI8x9X0bbaeUr/UKwPY aVo6hzET4k/gBbFOoK18y55HUB4Bo+5K+ueYMjnjxERuJ7dIPsmN2eUtakq2Ey1sFzf0+P2ZB/A/ hU88Euarv/Fj+KTHFe2YvMVH6VfEI7pLje/n8Xmp7/JA/AU3wNhnOvId3yXmbAcvteOy7tOfiyH5 sYPqe61IeWhAW0sBAJbGxr4dfKtvwhHyTg/xPS8CzOfFkOZTGIckx09LDzzg85txI6U698ON60AC ojWtGrVqbTRdbggloBjnI3+qpb1XC4bdOaQHkieUGNPpHRZ9gtJ8VnPeRv5dKlOYbh6yzFtzbykI c99Tbe9H3SvoWtSh73YJB1rUi5k8LbtkVZ8z8OdlftuR2+YnzI8e4BtKm+knzQp9egQQlJSFAKSo 7B+cY4DyS08Cc2Z3x7yBMbtDN3fQqHNlK6GVhtxxTJKzoJStt4kKPbY0SD2rXeJjJJ2P3iVfsB8Q +Q3GVcJHtC7PZ7m6Ylti9k9SltPFKNrKAE6G+vfbtuYq/qGspGGwIwYOOcJNH9K6pWbL5M5AcDOI ny2U88bD9zlcD4xJvcIQ7i7eoS5cYLSoMvGFJK0bSSDpRI2CR29TWdhnF3hQmYfYpd5YxMz37bFc lF299K/OLSSvqT5w0eonY0KifibmTLl4TeNbhcZb0qVKcs7z77zhW464q2vFS1KPdSiSSSe5JqQY dwz4Rp2I2Odek4/9oSLbGdl9eTvNq85TSSvaRIASeonY0NVhB0WzQSRk/D/sLM4e8u3ENaey34v9 FfHiwsWK434b7XZsIjxmbG1eGFw0xnS610uB9ZKVknqBUpR3s+tR3wTT5GK5dkHHlweI+1LPbsgi pV231strV0/UlElv8kfcakfizj4tB8ONptuFPxXbLBusSLDMaT7Q2lCG3UhIc6lFWta7kmoZep7X EeR8H8yLbULdPxGFbLkEg6V0Q0p2rQ/mvJI/+l91Xpf5LU0ty4u33kQfsqVyKV4K2waGzG0GQfLK gHikmyM35TzLIWVqNvxV2HY0n1057+07+XvokH8vxruDhr+KDBv827Z/ZW64svNilo8KM3PLqndw zHMUz3HNa6m0h5A9e/7Tzj/pV2nw1/FBg3+bds/srdUvyBQawbNMegH3WXhYJuX1HbuGr1Jj5KC+ LrOv3F8M3KLHe6JmQrFpZAPfocBLp7fLy0rH+kPwqiuHbXL4B5+xOxXF5aImbY9ES+FHsl99AIT3 9SJDfT9dL+/R3HicTe+Zuese4YxWQwldpjqcdW/sstvuI81anAAdhLSG/UHuoj51HvEZxvz3YbXa +TuQs7tV/cssttiO5CipZdjFautKz0tIBT1pSO+yCofU1ltqbW0W0XEDWDI552WC8qufXdXY0kUy ADyxl0+q6F5V4E4inY/lmZS8KiuXlcCbPVLLz3UZAaWoL0F9O+ob9NVTnhA4Z4y5E41uV7zTE490 nMXx6K26466kpaTHjqCdIUBra1H866FuGVRc44HuGXQ+kN3bF5MrpH8haoyutH+irafyqsPAZ/FB eP8AOSR/ZYtarKtVtq+XGQQN1uVKNB95TIaILSdhnZQ/mK1wLH4tOJrJaYyY8G3220xYzKSSG2m5 chKEgnZ7JAHfvV2eKT+IPL/6qz/aG6prxQPpxDxH8b8h3htxuysNxGnXwgkJLMtxbnf5kJeSdetT bxQctcdSuErzarVmFoucy9NstQ48KY28tf61CyohJJCQlJOz9w9TWQtdUdbuAnb6rGHspNuWuMb/ APzhb/wlutR/Dni8h9xLbbSbgtalHQSkTZBJJ+Q1XI+W2668sweRvEAy882m1XuEIhSTsR1KU2B9 QUJ9m/1+lXZJyGfxP4H7XDlBca6XuM7BipUClQTMfedJ+oPkKWQfrqtBx34e/EFL4jRYbLntgtWO ZVHE+Ra5MMKcV5yEfGssqWlRSlv0V20PTVZqJFF9SuSBLoE9Jk+q17gOr06VuGk6WSY6kQOmy6m4 uzFvkDjywZi2oFVzgtuPAa0l8e66nt9HErH5Vzp/c/f7y5n/AFmF/uO1s/A3lUlNhyTjC77bm49O MhtpXxJQ4ShxA/6LiCT97n/ZEfA9m2GYlactbyrLrLZlyZERTKbhPajFwJS5spC1Dq1sb19RWB1E 0qdem0c2x4TK2G3ArVLaq48nT4wAfmu0KVHrHyFgOUTjbMazjH7tLDZdMeDc2JDgQCAVdKFE6Gx3 186kNcotLTBC7bXNeJaZSlKVCslKUoiUpSiJSlKIlKUoiUpSiKtcv8OnDWd5FLyvK8O9uus7y/aH /tGU119CEtp91t1KRpKEjsPl9awLZ4VuBbPcYt2t2CeVLhPtyWHPtSarocQoKSrReIOiB2IIq2aV mFxWA0h5jxK1zaUC7UWCfAKIN8UYA1yA7ym3YNZQ8kIXO9qf7jyg1ry+vy/2aQn4flv1705A4o4/ 5SZhsZ5jqLom3rWuMS+6ypsqACtKaUk6Oh2J12H0qX0qgqvBDg4yNsrIaNMtLS0QcnG571FP0XYL +4H9GH2H/wAmfK8n2H2p74PM8zXmdfmfH3+Lf5dq2OI4jj2B49ExTFLd7Da4PmeQx5y3ejrcU4r3 nFKUdqWo9z8/pW6pUF73CCcb+fVSKTGkOAEgR5dPBanKcWsWa2CZi+TQfbLZPSESGPNW31gKCgOp BCh3SD2IqtP3onh4/o9/2tO/41XDSrMrVKYhjiPAqlS3o1TNRgJ7wCq/tHA3FFjxO7YPasV8iyXx SFz4vt0lXnKSQUnrU4Vp10j4SPSpNiOI49gePRMUxS3ew2uD5nkMect3o63FOK95xSlHalqPc/P6 VuqVDqr3iHOJ57qzKNOmQWNAjG3LoojgvFeB8au3F3CbGq2G6rS5LSmW+6hxSSrRCHFqSn4j8IH0 +Qrywnh7jnjq33O14djaYES8AJmtqlPvh4BKkgHzVqI7KUO2vWpnShq1DMuOd87xsoFCm2IaMbY2 nePFQvj7h3jjixyc9geNpti7kG0yVe1PvlYR1FIBdWrpHvq9Nb7b3oawbLwFxNj2N3nELNiqotpy ANi4x03CUS+EElI6y4VJHc/CRvejurCpUmtUJJLjnv6beigW9IAANECYwOe/rzWjw7C8Z4/sDGL4 ha02+2RlLW2yHVuEKWoqUSpalKUSSfUntoDsAK1WU8ScfZnk1rzLI8fMm9WUt+wzES32Vs+W4XEd m1pCtLJI2D6mpjSoFR4dqBM9VY0qZaGFogcowopnPFfHvJTTbWb4pCuhZSUtOrCkPNpPcpS6gpWB vvoHW6j0Lw38JW6w3DG4eBRW4N0QhuX/AAh8vOIQ4lxKfOK/NCetCDoKAPSN7FWZSpbWqNGlriB4 qrrei92pzAT4BQ3I+IuPMtxC14HkOPe12Ky+R7DE9rfb8ryWi0376FhatIUR7yjvezs96iH70Tw8 f0e/7Wnf8arhpUtuKrBDXEeZUPtaFQy9gPiAoC/wXxXIwaPxq9i3VjkWSZjML26SOl4lR6vMDnmH utXYq139PSsrJOHuOMvxS04RkWNpmWWxpZTb4/tT6CwGmi0gBxCwsgIOu6jvsTsgGppSo99UmdR6 781P6elEaRtGw26eChl34f45v2EweOrpjaXsdtpbVFhCU+jyygEJPWlYWfiV6qO97O6ktmtFux6z wbDaI/s8C2xmokVrrUvy2W0hCE9SiVHSQBskn61nVxhA/wAH5cv6yn/zVus1Km64EF38gP8AtOfk sFeqy1MtaJ0k9MNjHz8l0/ZuJeP7Dms/kW14/wCVkNzDiZM1ct90rCyCrSFrKE/CB7qRodhoEitz lWLWDNrBMxfKLcmda56UpkR1LUgLCVBQ95JCgQpIOwQe1c943c52M8Rcm8JX6QtyVjWM3CdaHXD7 0m0vxXFNn7y2pRQr5DaQPSre4E/iWwr/AOyRf/5iprU3s7ZdMEAeESCot6tOp/jDAAQSR3zBB/PN bmxce4hjOHKwCy2pTFhWy+wYipTzmm3iouJC1rKwCVq9FdtnWq+cC45w3jGzvWDB7P8AZsCRJVMc a9ode28pKUlXU6pSh7qEjW9dvxqhOIuHuNuR8n5TueaYszc5UbObnHZdW862pDfmFWh0KHzJO/Wp Hgarnx/ybmXCqb1NuVgGPnILOia6p52C2VBtxgOKOyjqVsA+gA+ZUTZ9I9pgeSdz3/Myc81SnWHY eaYAyARy7thAMclc+TYnjeZ2pdjyuyRLpBcIUWZLYWkKHoofNKh9Ro1BbL4ZOCrBckXW3cdwvaEL C0mS+/JQlQOwQh1akDv91c4cLfvRf0Z2f9KH2Z+6b+Ee3ed7X1/84c8vfl+7+z8v0+WvnupxzxF4 qg8jcQQcwajtYLHtU9ooc83y0x0x0iOPd/WaCg1r5/X51mFvUpvNFrnAZ5RMDlnMrAbmlWpiu9jC cc5Ikjfs4hX1n/FWB8oxocPOrGq5MW9anI7YlvsJQpQAJ00tOzoD13rvrWzUqZZajsojsNpbbaSE ISkaCUgaAA+Q1XM3FsXApHONuf8ADxJeTi0O2yDlLbTz4iKcWkiMEoeOy51gElI1pJ7/ABVEeAZU jFOdLpe3XVC3Zbkt+x13Y9xEhgtSGSfoVda0j8T+NYzauLSNR7IkAj5RONp71kbeNa8O0DtGCQek QZjIzHdldN2LiTj7GszuPINix/2S/XbzfbZSJb5D3mKC17bKy33UkK7J9Ruod+9E8PH9Hv8Atad/ xqprl2VIyvxH47kiXFG343mVhxiLo+6t7zDIkHX1SpSE7/CsnKP0GfvlOSf03ex+R5Vp+zvafP8A j9jb8zXlfd0+v5VlZRrAAio6S2cTO4Eb9/ksL69B0tNNsB0ZgDIJJ2O8eavzBuBeJ+Nr0rIsKxT7 OuCmFRi97dJe/VqIJHS44pPqkd9b7VYNV/wxE4iZxmRK4aaips0iYrzlRy90qfSlIP7XvsJ6fuqw K0KxcXnWST37/ddS3axtMaAAD02+gSlKViWZKUpREpSlESlKURKUpREpSlESlKURKUpREpSlESlK URKUpREpSlESlKURKUpREpSlESlKURKUpRErmOJw5yO14PZvFi8c1lDz4WiD7Yx3H2gh3fmdfl/s 0lXxfd69q6cpWalWdS+HqD6f7WvWt21/i6EeRifoqK5/4ly7K8Ytt+wCKleU2+2vWZ+MXUNiZBlM ll5oqWpKNo6itOzrYVrZ1VjcR2K64vxhi+O32J7NcLda48aSz5iV+W4lACk9SSUnR+YJFS+lHV3P pimdgjLZlOqaw3IjuXPWDROZ+Msiz1MHhl6+w8iyqdd4kpN/hRkllxw9G0qUVDYAPcbG9a3UqwHj nME3vKeTc/VDTkuSQxAjW6G51s2+Ige4z5h11rKtFR9NjY9e1t0qz7lzpwATuc/n6KjLRrIlxIGw MYnwA681ztw4/wA58WccWjA5HAkq4uWz2jclGS29sOeY+478JWda8zXr8qlF7xXN8m5h4s5AexZU CJZ4Vy+2G1TWXDBdfjFCGyQrbnvHW0Aj59hVw0qXXJc4vDQCZnfnvzRloGsFMuJAiNv4kEcu5Vbd MIv0TxCWTkKy2gKtUyxSbVeZDTzaOhaVBxlS0FQU5sgJ2kKI0N6AquYvDPIcfjnKgzYktZNF5Ddy 7HmVSmdSEpUz0HrCylHUgOjSiD2GwK6YpRt09kRGI+X99EfZU3kkk5n5gfifFc2p4az9GJ8al6yJ dvkfO2sryfpksjySt9S3V7K9LKU9CdIKientutwq2cs4Rzlnma4/xU9ktqyVq2txnm7zDia8iMhC yUuL6vi6h3A+HfcEVfVKk3bzOoAzPXmZ69yqLFjY0uIIg8uQI5joVGcIv+X3+JJey/AXcWeacCWW XLkxMLydbKtskhOj20e9SalK1nEEyBC22gtEEz/e6EpSlQrJSlKIlKUoiUpSiJSlKIlKUoiUpSiJ SlKIlKUoiUpSiJSlKIlKUoiUpSiJSlKIlKUoiUpSiJSlKIlKUoiUpSiJSlKIlKUoiUpSiJSlKIlK UoiUpSiL/9m= ------=_NextPart_01D7EA15.3E0692F0 Content-Location: file:///C:/E87559EC/RESUMOSSGWACm2021GANHADORESHTML_arquivos/image002.png Content-Transfer-Encoding: base64 Content-Type: image/png iVBORw0KGgoAAAANSUhEUgAAAKcAAAA7CAMAAAFea1pwAAAAAXNSR0IArs4c6QAAAARnQU1BAACx jwv8YQUAAAJhUExURQAAADAyMOzs7JuinMbGxoaMh0ZJRgYGBlNTU+3t7YeNhwAAAAcHB1RUVO7u 7p2knnt7e8jIyEhLSAgICAkJCfDw8J+mn5+moDAwMIqQigoKCvHx8aCnoTExMX5+fsvLy4uRjEtO SwAAADo+OwsLC6WlpfLy8jIyMjs/PAwMDFlZWTc5NzMzMw0NDaenpzg6OFJXUw4ODjk7OaSrpQ8P D/b29jo8OoODgz9DQBAQEPf396atp5Wdljc3N9HR0REREaurq/j4+IWFhQECAVNWUxMTE62trfr6 +tTU1IOKhBQUFGFhYQMEAwMEBPv7+xkbGURIRfz8/FpfWzw8PNbW1v39/TAzMIaNh2RkZLGxsf7+ /tjY2IeOiBgYGAcIB7Kysv///52lnj8/PxkZGV5jXi8wLxoaGmdnZ7S0tNvb24qRixsbG6Coodzc 3BwcHIeMh2lpaQsMC7a2tqGpopCQkN3d3WpqagwNDDc6OJGRkSIkInh+eTg7OaOrpJKSko6VjwAA AA4PDg4PD3l/eqSspY+WkCAgIA8QD3qAe6WtpkdHR2VqZuHh4VBUUCEhIRAREHuBfKaup0hISJWV lSIiIm9vbxESEaevqOPj4xITEqiwqeTk5JOalCQkJH6Efr6+vj5BPqmxqktLSykrKeXl5SUlJXJy cr+/vxQVFaqyqz9CQExMTObm5pWclgAAAJadlycnJxYXFnR0dIGHggEBAWxxbU5OTpubm+jo6Cgo KHV1dYKIgkJFQgICAunp6SkpKQMDA+rq6pmgmioqKhkaGURHROvr61peWysrK8XFxQUFBZX3m20A AACBdFJOUwD/////////////nf////////////////////////////+a//////////////////// //////////////////////////////////////////////////////////////////////////// ////////////////////////////nuPGtPAAAAAJcEhZcwAAIdUAACHVAQSctJ0AAAYtSURBVFhH 1ZmHfxRFFMfPLjFiiR2xIIqoqFHsBRHFXlCxYBt7x46KYscuGisqlthP47NFBTUYxf5X+cpv9nZn Zy+zl5APfuHm3rz5zW/ezu5ecptGgyI0qNkkfinkEHHWMdZxPs0GLusUsvJfO+Rm67s4vJw5ZLBW VsPabKZEC6vKSrmoklfb3YIGh+ymMZeCZRtSJGoIsr7jJxUcWjRouEnNF23pNSi3sl5MGhmVynq8 4iOWUt7g/p+uBz2FpSYUcitwUjcQXUGlr4gsKr0GXUEKEJWQ7aayc7ErUj1hJpxhh1qB7YvO0qhF tnWe+BbGaPAZT0QuDr+0JjK4/GMLKZXqUbkbigO6ffmUXnJTRcnkBjaSHXFuNbqCSqEsnYHLC3eD SfmfNkgygzKTX+gKXqr5LTdAlrFUqVbZ61vEF0lF5hYTFbUy4faJ1GtpheUqkBPL7TLn3qV9w6sg QK+s5gvaasIzgPcWrSvrMo0yWBpcWulXFku15jGlYHqWrYNeFUtN1UbWMmXZQj0PG3J0PpJl7Mr+ hF9T6Q/kQrwp0cci9hDdrOkSNFOGz7ProKpamNr6OYi6dTzAdHLwfHdwgHSAmapWpOTO1Laqirqm v6ieJ+ib+5G2MEURL4I5sgGFSvll7UTnhqommNRa5EJyps6tr+0CbasvGTn4U6VBv0x2onrVyrOg zZSRYVNbk1sYOrc/0aNWUYfgjjZbD/eWICwzwMvq3qMfIfuYkLozkIvCpvPZ8mJ0YwSfPWfMQVCN VtquzlofaOk0HkYwdmzW2Bu7OHbs0bgA0djRlfN83Uq/BN0qTEXvoVum5fkQtMx0pGLwwofJzcEy ZEpknuI1X8R6mVguht5zk0yHVIj3ZB/RGW1MTeZbJAPgWbBsYzpkMppsb8gGZJ4qyiB6TYdDfIF4 n4N0EfMkOkQ0OSoKRZneMy7ynqrNMWrPc+gIKHfVVibE9emeMOHXP4voGfdgT6WethWv1WaZ5ulb DaAoYMOZ5ylIF6npaQcPzwpJeOwLp9Fpbp51oSiiUvM8l45CMkA9D6Rp6kJ0t7ZtPNl0Lo+q4Guk QtQT2+RO0vZXaYi2N0EJWXOWNFWComeOqjIFMaSl6EQwz5IpVdx2SWSeBVPu6mhndMkPzicDU7V8 k9sO0R/GbC5vmaNPdIj9gGePfg2UwbaWsiwvrGvHwS8N7OJ9HmuFURx1TyS3w8iedLW6epCMottj W1SB9yS6FX4jbaUdd5qnMHw6gjZwnd11PMeGteI5he79dl3nAJrSIL3h13G6+BxV1nnnlyu+uALx 6Ogbxtkj+g2pesTr/A6eLTbBSCfAIkfFc4I2ROr8F2bM94tuW4WQeRqCesjMPeVj2TNbMosxmkqp TjEhehWeHv46KNwDUToyCx5y6hG+zSEEiQR1ii19BLcAHTsbwkR4BmbbfITaORyaJAp1Pi9Wm8Mp ggzX2geWY2oJHjoaqhTydW4jZcAmzlaigDoBvtJXY6YdI6MPqASOIUshV+cHYgOTKuaJxuQJ5P1k ojD6OsUFHsdJTOSfYQlPaOyul9j0I8NSm8XIPGHUdYqJOXwl4YxLLSEtLdNWByVQfQJ+jtBrf0Dp vQP90dc5l4N9JNiLX1nWcyUnVJ/AO0RDmKbff/Jek2r4MJE6p+ftsqznLk7sqBMSYG32IRfUyTFE SUTqvI+DCzVisuwEbZ17iROqT+J2Pz2o88RaLkzs+uyRcPBaS0hLf2urgxKoPpFs4oT9BA3ljK2H 8URadeYKdZMlLt7vqzR2J0ts+kTsgd0PNt25D7X7MwaTydW5mOcPw60SWcTkNbhRZrU4FOk65Ops 6tcY1BPnOVH0Q16X/r6+TqcW62x+JmXsgpoiyHD93RwTpM4Htha0q5W8j7ICdEwvf9WPLwdxneBx KQEPBrLPJYDfP2eKxA5m3Ml9h9UqmkPoEc36/Phvbmr9er9Eh59Cb7zJf9eWZyvCs+i36MHIdujX YsCtXL7SuYvoLXek3KnHIF+L4JkA6lF++mvjE+5HrPwOUU0G3Bqi5W4nok3l74jI1qT87OJgVBXQ jeH6aJ1XWYGdlhmpUxjeDdUpnyLbIVrndWulznWP/0edRP8BH8adHGjCDpYAAAAASUVORK5CYIJ= ------=_NextPart_01D7EA15.3E0692F0 Content-Location: file:///C:/E87559EC/RESUMOSSGWACm2021GANHADORESHTML_arquivos/filelist.xml Content-Transfer-Encoding: quoted-printable Content-Type: text/xml; charset="utf-8" ------=_NextPart_01D7EA15.3E0692F0--